Evaluation of cell types for assessment of cytogenetic damage in arsenic exposed population by Ghosh, Pritha et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Molecular Cancer
Open Access Review
Evaluation of cell types for assessment of cytogenetic damage in 
arsenic exposed population
Pritha Ghosh1, Arindam Basu1, Keshav K Singh*2 and Ashok K Giri*1
Address: 1Molecular and Human Genetics Division, Indian Institute of Chemical Biology, Kolkata-700 032, India and 2Department of Cancer 
Genetics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
Email: Pritha Ghosh - pritha_ghosh2002@yahoo.co.in; Arindam Basu - arin.basu@gmail.com; 
Keshav K Singh* - keshav.singh@roswellpark.org; Ashok K Giri* - akgiri@iicb.res.in
* Corresponding authors    
Abstract
Background: Cytogenetic biomarkers are essential for assessing environmental exposure, and
reflect adverse human health effects such as cellular damage. Arsenic is a potential clastogen and
aneugen. In general, the majority of the studies on clastogenic effects of arsenic are based on
frequency of micronuclei (MN) study in peripheral lymphocytes, urothelial and oral epithelial cells.
To find out the most suitable cell type, here, we compared cytogenetic damage through MN assay
in (a) various populations exposed to arsenic through drinking water retrieved from literature
review, as also (b) arsenic-induced Bowen's patients from our own survey.
Results: For literature review, we have searched the Pubmed database for English language journal
articles using the following keywords: "arsenic", "micronuclei", "drinking water", and "human" in
various combinations. We have selected 13 studies consistent with our inclusion criteria that
measured micronuclei in either one or more of the above-mentioned three cell types, in human
samples. Compared to urothelial and buccal mucosa cells, the median effect sizes measured by the
difference between people with exposed and unexposed, lymphocyte based MN counts were found
to be stronger. This general pattern pooled from 10 studies was consistent with our own set of
three earlier studies. MN counts were also found to be stronger for lymphocytes even in arsenic-
induced Bowen's patients (cases) compared to control individuals having arsenic-induced non-
cancerous skin lesions.
Conclusion: Overall, it can be concluded that MN in lymphocytes may be superior to other
epithelial cells for studying arsenic-induced cytogenetic damage.
Background
Exposure to inorganic arsenic through drinking water
results in cancers of skin, urinary bladder, liver and the
lungs. Cytogenetic assays play an important role in toxico-
logical hazard evaluation as the first step towards quanti-
fication of cancers. Various genetic toxicological end-
points have been used as biomarkers to understand the
biological effects of arsenic exposure [1]. Biomarkers serve
as internal indicators of environmental or occupational
exposures and have the potential for prevention of effects
of carcinogen exposure by early detection [2]. Micronuclei
are the potential biomarkers and traditionally been used
for biomonitoring of genotoxic effects in humans [3].
Micronuclei are chromosomal fragments or the whole
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chromosomes that are not included in to the daughter
nuclei during cell division and are incorporated as much
smaller nuclei. The formation of MN is therefore induced
by substances that cause breakage of chromosomes (clas-
togens) as well as by agents, which affect the spindle appa-
ratus (aneugens). The speed and ease of MN analysis, and
non-requirement of metaphasic cells made this assay very
popular.
In West Bengal, India, the ground water in nine out of
eighteen districts is heavily contaminated with arsenic.
More than 6 million people are endemically exposed to
inorganic arsenic in their ground water, which exceed the
maximum contamination level of 10 μg/l [4,5]. Although
only 15–20% of the population exposed to arsenic shows
clinical features of chronic arsenic poisoning, the remain-
ing individuals are also at risk of developing arsenic-
induced health effects [6]. Therefore, genetic monitoring
of population exposed to arsenic through drinking water
is important. Numerous population-monitoring studies
have been carried out in various arseniasis endemic coun-
tries such as Mexico, Finland, Taiwan and Argentina to
determine genotoxic potential of arsenic [1,7-9].
MN assay are conducted in lymphocytes, urothelial, and
buccal mucosal cells. Cytokinesis-block micronucleus test
(CBMN) in human peripheral blood lymphocytes is a
standard cytogenetic test for genetic toxicology testing
[10]. The use of exfoliated cells for MN assays has become
well established in epidemiological studies aimed at
defining genotoxic effects on target tissue following
chronic exposure to epithelial carcinogens [2]. We have
been working on the mutagenic and genotoxic effects of
different drugs, chemicals and environmental toxicants,
including arsenic [11-16]. Last five years we have been
working on the assessment of cytogenetic damage as
measured by MN assays in three cell types i.e. lym-
phocytes, urothelial cells and buccal mucosa cells in the
population exposed to arsenic through drinking water in
West Bengal, India.
Peripheral lymphocytes can be used as surrogate target
cells [17]. Collection of lymphocyte is socially and ethi-
cally acceptable, and involve minimum invasive route.
The cytokinesis-block micronucleus (CBMN) technique
in lymphocyte culture is widely regarded as a sensitive and
reliable method for assessing chromosome damage [18].
It is based on the use of cytochalasin B, an inhibitor of
actin polymerization, which blocks mitotic cytokinesis
without preventing nuclear division. In this assay MN are
scored after a single cell division using binucleated lym-
phocytes to eliminate the confounding effect of altered
cell division kinetics on the MN index [18].
Exfoliated epithelial cells have traditionally been used for
cancer screening and bio-monitoring of genotoxic effects
in human [3]. Large number of these cells can be rapidly
and non-invasively collected from study participants. The
frequencies of MN observed in exfoliated cells of buccal
mucosa and urinary bladder serve as an appropriate index
to monitor the genotoxicity induced by arsenic because
these cells are in direct contact with the carcinogen [2].
MN in urothelial cells reflects damage to the bladder epi-
thelial tissue, which occurs approximately 1–3 weeks
prior to the exfoliated cells appearing in urine [19].
Although all three-cell types provide important informa-
tion about cytogenetic damage, selection of an appropri-
ate cell type is important. On one hand, life span of
lymphocytes is higher than that of the other two exfoli-
ated cell types, and on the other hand, turn over of exfoli-
ated epithelial cells is variable, therefore, it is reasonable
to assume that lymphocytes might yield higher MN
count/1000 cells compared to other exfoliated cells.
We earlier reported MN counts in three different cell types
from the same individual. In this paper, we extend the
research based on our systematic literature review and
comparing the summary data with findings from our ear-
lier research. We have also conducted a matched case-con-
trol study taking arsenic-induced Bowen's patients as cases
and age-sex matched individuals with arsenic-induced
non-cancerous skin lesion as control. The purpose is to
study (a) which cell type show stronger effects on arsenic
exposure and (b) whether this cell type is also similarly
informative for cancer patients.
Search strategy & inclusion/exclusion criteria
We searched the Pubmed literature database using the fol-
lowing keywords in various combinations: "arsenic",
"micronuclei", "drinking water", and "human" [20]. We
restricted our selection of studies to those published in
English language only since we did not have facilities for
translations nor did we have access to translation services.
Initially, titles and abstracts were scanned to identify
whether the study met the minimum inclusion criteria to
be retained for review. We selected only case-control stud-
ies. If the study met the minimum criteria, then full text of
the study was obtained. Data were abstracted from each
study to a pre-defined database and the database was pre-
pared for analysis. The reference section of each study was
scanned to identify other similar articles.
A study was included in our review if it contained the fol-
lowing information as minimum: clearly written methods
section, unbiased or minimally biased measurement of
arsenic exposure, micronuclei counts per 1000 binucle-
ated cells either in one or more of the three cell types, such
as- lymphocyte, urothelial and buccal mucosa cells, andMolecular Cancer 2008, 7:45 http://www.molecular-cancer.com/content/7/1/45
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clear presentation of the results in the format of difference
in effect sizes of MN per 1000 cells. Where the counts were
not reported per 1000 binucleated cells, if the study met
the other criteria and was accepted, we converted the fig-
ures to reflect changes per 1000 cells and rounded off the
decimal points to two places after zero. Studies with non-
human samples were also excluded.
Analysis of literature review
Our literature search retrieved initially a list of 20 publica-
tions. After filtering through inclusion and exclusion crite-
ria, we found 13 studies to be eligible (Table 1).
Lymphocyte as a cell type for MN assay
To our knowledge, only five studies document lym-
phocyte as a cell type for arsenic-induced MN formation.
About 5 fold increase in MN lymphocytes was observed
among native children and women of northwestern
Argentina exposed to high level of arsenic via drinking
water in contrast to controls by Dulout et al., 1996 [9].
Higher number of MN formation in lymphocyte due to
arsenic exposure was observed from the studies of Mar-
tinez et al., (2004) in the population of Northern Chile
[21]. Since a large number of individuals are exposed to
arsenic in West Bengal, India, three separate studies were
conducted from different region of West Bengal, India and
it was observed that, MN in lymphocyte is much higher in
cases compared to control [15,16,22].
Urothelial as a cell type for MN assay
Relatively more studies were performed with urothelial
cell for MN assay. Studies by Warner et al (1994) in a pop-
ulation exposed to arsenic in Neveda, USA showed about
1.8 fold increase in the mean frequency of micronucleated
urothelial cells compared to control [23]. Using advanced
technology for detecting MN by fluorescent method,
Moore et al (1996) observed similar result for urothelial
cells [24]. Further, they have showed higher prevalence of
MN in urothelial cell in cases compared to control, in
Chilean population [25]. To find out the relationship of
urinary arsenic (an estimate for arsenic intake) and a
biomarker of effect, prevalence of MN was found to be 2
fold higher in cases compared to control [26]; while Gon-
sebatt et al. (1997) have shown 4.65 fold increases [7];
and Tian et al (2001) observed about 3 fold increases in
mean MN count for urothelial cells in cases [27]. All the
three studies from our group strongly support increase
mean MN count in urothelial cell in arsenic exposed cases
compared to control [15,16,22].
Buccal mucosa as a cell type for MN assay
Gonsebatt et al. (1997) have shown about 3.8 fold
increase in MN in buccal cells in exposed individuals com-
pared to unexposed [7]. Similar inference was also
obtained from the studies of Tian et al. [27]. MN fre-
quency in buccal cells of arsenic exposed population from
Antofagasta region, North Chile was shown to be higher
compared to the referent individuals from Concepcion,
Chile; but not statistically significant [28]. Again, a recent
study by Chakraborty et al. (2006), on 45 arsenic exposed
individuals from West Bengal revealed 3.34 fold increases
in MN in buccal mucosa cells compared to 25 controls
studied [29].
Table 1: Micronuclei in three different cell types for all the studies included in the review
Effect size [Exposed; vs. Unexposed; Mean (SE)]
Sl no. Author, Year [Ref No.] Sample Size N (Exposed; 
Unexposed)
Lymphocyte Urothelial Buccal
1 Warner et al., 1994. [23] 36 (18,18) - 2.79 (0.73) vs. 1.57 (0.28) -
2 Moore et al., 1996 [24] 36 (18,18) - 2.8 (NA) vs. 1.67 (NA) -
3 Dolout et al., 1996 [9] 44 (22; 22) 38 (3.2) vs 6.9 (1.7)
4 Moore et al., 1997 [25] 125 (70; 55) - 3.2 (NA) vs. 2.6 (NA) -
5 Biggs et al., 1997 [26] 104 (83; 21) - 3.34 (NA) vs. 1.61 (NA) -
6 Gonsebatt et al., 1997 [7] 69 (35; 34) - 2.23 (0.99) vs. 0.48 (0.10) 2.21 (0.47) vs. 0.58 (0.13)
7 Tian et al., 2001 [27] 32 (19; 13) 1.44 (0.37) vs. 0.53 (0.14) 2.21 (0.36) vs. 0.65 (0.21)
8 Basu et al., 2002 [22] 65 (45; 21) 6.39 (0.25) vs. 0.53 (0.07) 5.74 (0.27) vs. 0.56 (0.1) 5.15 (0.3) vs. 0.77 (0.11)
9 Basu et al., 2004 [15] 317 (163; 154) 9.34 (0.153) vs. 1.66 
(0.061)
6.65 (0.13) vs. 1.41 (0.05) 5.94 (0.15) vs. 1.28 (0.05)
10 Martinez et al., 2004 [21] 217 (106; 111) 14.44 (0.99) vs. 11.96 
(1.02)
--
11 Martinez et al., 2005 [28] 207 (105; 102) - - 3.14 (0.32) vs. 2.74 (0.26)
12 Chakraborty et al., 2006 
[29]
70 (45; 25) - - 9.8 (0.7) vs. 2.9 (0.1)
13 Ghosh et al., 2006 [16] 306 (204; 102) 7.76 (0.17) vs. 2.03 (0.08) 5.13 (0.13) vs. 1.70 (0.07) 4.62 (0.15) vs. 1.67 (0.06)Molecular Cancer 2008, 7:45 http://www.molecular-cancer.com/content/7/1/45
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Finding best suitable cell type
From the reported data in each study, first, effect sizes
were calculated as follows. Effect size was defined as the
difference in the mean value of the cases versus controls.
The mean value of micronuclei count per 1000 for con-
trols were deducted from the mean value of the micronu-
clei per 1000 for cases, and the difference was identified as
the effect size for the specific study. Effect sizes were calcu-
lated for all studies identified by the previous search strat-
egy. All studies did not calculate the values for
micronuclei counts for all three-cell types in the same
individual. In that case, we treated non-reported data as
missing for that study.
Since this review was not a meta-analysis, but a structured
mini-review of observational studies, we did not conduct
formal tests of heterogeneity or homogeneity of studies
for this review. We plotted the medians of the effect sizes
of each cell type as individual bar charts to show the visual
differences in effect sizes among the three cell types. We
reported further pairwise comparisons for the three com-
binations: lymphocyte versus urothelial cells, lymphocyte
versus buccal cells, and urothelial cells versus buccal cells.
We used the nonparametric Wilcoxon rank sum tests for
the pairwise comparisons with a pre-specified significance
level of 0.05. We conducted the tests for two sets of stud-
ies: (i) all studies taken together and (ii) studies that were
reported from our research group.
Wilcoxon rank sum test for the pairwise comparison for
median effect size (based on MN counts) in three cell
types for the full set of studies (Table 2) as also studies
conducted by our group (Table 3) was calculated. Review-
ing all the studies, it was observed that, lymphocyte is a
better candidate compared to other two (Fig. 1). Similar
inference was observed from the studies of our group,
where MN counts were taken for all the 3 cell types for
each individual. The data also supports that lymphocyte is
a better cell type compared to other two (Fig. 2).
Is the observation also true for arsenic-induced Bowen's (in 
situ carcinoma) patients?
To evaluate whether the best suitable cell type suggested
from literature review, also applicable in arsenic-induced
Bowen's cases, we considered 25 cases of histopathologi-
cally confirmed arsenic-induced Bowen's patients from
our epidemiological survey [30] and conducted a
matched case-control study taking non-cancerous skin
lesions individuals as control. These histologically con-
firmed 25 cases of Bowen's disease (designated as "case")
were pair wise matched with 25 cases of non-cancerous
arsenicosis individuals (designated as "control") on age,
gender and smoking status (Table 4). The selection of con-
trol individuals was done via the generation of random
numbers using MS-Excel spreadsheet program. Micronu-
clei results for all three cell types of these Bowen's cases
were not reported elsewhere.
Comparing the mean MN count for three cell types
between cases and controls, we found MN count was sig-
nificantly increased in cases for all the cell types, i.e. in
lymphocyte, urothelial and oral mucosa cells (Table 4).
To our surprise, MN count in lymphocyte was 1.9 fold
higher compared to oral mucosa cells and 1.6 fold higher
compared to urothelial cells, in both cases as well as con-
trol (Table 4).
Conclusion
All the studies on arsenic exposed populations clearly
demonstrated a significant genotoxic effect in lym-
phocytes as well as exfoliated epithelial cells. We have
found that overall, compared to urothelial cells and buc-
cal mucosal cells, the median effect sizes for lymphocyte
based MN counts were stronger. This inference was further
supported by the general pattern pooled from other 10
studies conducted by different groups. Lymphocyte based
MN count was also stronger for arsenic-induced Bowen's
patients. Therefore, it can be inferred that lymphocyte is
the most suitable cell type for studying cytogenetic dam-
age.
The findings from our review need to be interpreted in the
light of its several limitations. We considered here only
studies in English language. There may also be additional
unexplained variabilities, including scoring variability
among different study groups. Exposure level of the study
groups also varies considerably, which might influence in
outcome. It has been known from in vitro studies that,
Table 2: Wilcoxon rank sum test for the pairwise comparison for median effect size (based on MN counts) in three cell types for the 
full set of studies
Median value of the effect size of MN countsa
Lymphocytes Urothelial cells Buccal Mucosa cells Comparison Significance
5.86 1.73 Lymphocytes vs Urothelium 0.04
5.86 2.95 Lymphocytes vs Buccal cells 0.11
1.73 2.95 Buccal cells vs Urothelium 0.48
a Effect size = MN count of cases – MN count of controls.Molecular Cancer 2008, 7:45 http://www.molecular-cancer.com/content/7/1/45
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Table 3: Wilcoxon rank sum test for the pairwise comparison for median effect size (based on MN counts) in three cell types for the 
studies conducted by our group
Median value of the effect size of MN countsa
Lymphocytes Urothelial cells Buccal Mucosa cells Comparison Significance
5.86 5.18 Lymphocytes vs Urothelium 0.05
5.86 4.38 Lymphocytes vs Buccal cells 0.05
5.18 4.38 Buccal cells vs Urothelium 0.10
a Effect size = MN count of cases – MN count of controls.
Comparison of median effect size (with error bar) based on micronuclei counts among lymphocytes, urothelial, and buccal  mucosa for all the studies in the review Figure 1
Comparison of median effect size (with error bar) based on micronuclei counts among lymphocytes, urothelial, and buccal 
mucosa for all the studies in the review.
Comparison of median effect size (with error bar) based on micronuclei counts among lymphocytes, urothelial, and buccal  mucosa for the subset data (set of studies from our group) Figure 2
Comparison of median effect size (with error bar) based on micronuclei counts among lymphocytes, urothelial, and buccal 
mucosa for the subset data (set of studies from our group).Molecular Cancer 2008, 7:45 http://www.molecular-cancer.com/content/7/1/45
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MN prevalence increase along with exposure but again
return to baseline when, exposure is highest, possibly, due
to inhibition of MN formation at high doses due to cyto-
toxicity/cytostasis [31,32].
Arsenic generates reactive oxygen species (ROS) including
peroxy radical, superoxide radical, and hydroxyl radical
and these in turn cause DNA damage [33]. Moreover,
arsenic is a known clastogen and an aneugen, which could
give rise to chromosomal mal-segregation leading to MN
formation. Significant chromosomal aberrations are
observed in peripheral lymphocytes when exposed to
arsenic [1,7,8,16,34]. Except for a few negative results, the
majority of the cytogenetic studies clearly indicated a pos-
itive clastogenic effect in population exposed to arsenic.
Since, chromosomal aberration primarily lead to MN for-
mation, lymphocyte can be used as suitable biomarker to
study genotoxic effects of arsenic.
In conclusion, lymphocyte is an excellent as also the most
suitable cell type for the analysis of cytogenetic damage as
measured by micronuclei formation in the individuals
exposed to arsenic through drinking water, and is also
applicable in arsenic-induced Bowen's patients.
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